Catalina Capital Group’s Eli Lilly LLY Stock Holding History

Catalina Capital Group’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.12M	Buy	1,214 +17	+1%	+$17.2K	0.67%	28
2025 Q4	$1.29M	Buy	1,197 +19	+2%	+$18.2K	0.78%	28
2025 Q3	$899K	Sell	1,178 -5	-0.4%	-$3.72K	0.55%	43
2025 Q2	$922K	Sell	1,183 -419	-26%	-$326K	0.61%	37
2025 Q1	$1.32M	Sell	1,602 -2,723	-63%	-$2.27M	0.86%	27
2024 Q4	$3.34M	Buy	4,325 +43	+1%	+$35.6K	1.1%	18
2024 Q3	$3.79M	Buy	4,282 +354	+9%	+$318K	1.27%	14
2024 Q2	$3.56M	Buy	3,928 +290	+8%	+$232K	1.34%	12
2024 Q1	$2.83M	Buy	3,638 +1,694	+87%	+$1.21M	1.18%	16
2023 Q4	$1.13M	Buy	+1,944	New	+$1.13M	0.76%	29

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Catalina Capital Group's LLY Position: Q1 2026 in Review

Catalina Capital Group increased its Eli Lilly (LLY) stake by 1.4% in Q1 2026, buying an estimated $17.2K and bringing the position to 1,214 shares worth $1.12M. The position accounts for 0.67% of the portfolio, ranked #28.

Catalina Capital Group first reported a position in LLY in Q4 2023 and has held it in 10 quarters since. The position peaked at $3.79M in Q3 2024. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

Catalina Capital Group held 1,214 shares of Eli Lilly worth $1.12M as of Q1 2026.
Catalina Capital Group bought 17 Eli Lilly shares in Q1 2026, an estimated $17.2K.
Eli Lilly made up 0.67% of Catalina Capital Group's portfolio in Q1 2026, its #28 holding.
Catalina Capital Group first reported a position in Eli Lilly in Q4 2023 and has held it in 10 quarters since.
Catalina Capital Group's Eli Lilly position peaked at $3.79M in Q3 2024.
4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Catalina Capital Group's 13F filing for Q1 2026, filed 23 Apr 2026.